Home
NGHIÊN CỨU LÂM SÀNG
Issue: Số 91+92, 2021
Article
Trần Bá Hiếu: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;
Nguyễn Duy Tuấn: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;
Đào Hồng Quân: Bệnh viện Đa khoa tỉnh Ninh Bình;
Phạm Thị Thanh Thảo: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;
Nguyễn Thị Thu Hoài: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;
Trần Ngọc Dũng: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;
Published: August 1, 2020
Views: 120
References
1.
1. Williams Bryan, et al. (2006). Differential Impact of Blood Pressure-Lowering Drugs on Central Aortic Pressure and Clinical Outcomes. Circulation, 113(9), 1213-1225.
2.
2. ManciaG.,RoseiE.A.,AziziM.,etal. 2018 ESC/ESH Guidelines for the management of arterial hypertension. 98.
3.
3. Levey A.S., de Jong P.E., Coresh J., et al. (2011). The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. KidneyInt, 80(1), 17-28.
4.
4. Izzo J.L. (2014). Brachial vs. Central Systolic Pressure and Pulse Wave Transmission Indicators: A Critical Analysis. AmJHypertens, 27(12), 1433-1442.
5.
5. Vlachopoulos C., Aznaouridis K., and Stefanadis C. (2010). Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol, 55(13), 1318-1327.
6.
6. Safar M.E., Blacher J., Pannier B., et al. (2002). Central pulse pressure and mortality in end-stage renal disease. HypertensDallasTex1979, 39(3), 735-738.
7.
7. GoupilR.,DupuisD.,AgharaziiM.,etal.(2017). Central blood pressures in early chronic kidney disease: an analysis of CARTaGENE. NephrolDialTransplant, 32(6), 976-983.
8.
8. Woodard T., Sigurdsson S., Gotal J.D., et al. (2015). Mediation analysis of aortic stiffness and renal microvascular function. J Am Soc Nephrol JASN, 26(5), 1181-1187.
9.
9. Toussaint N.D., Lau K.K., Strauss B.J., et al. (2008). Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease. NephrolDialTransplantOffPublEur DialTransplAssoc-EurRenAssoc, 23(2), 586-593.
10.
10. esc_admin Khảo sát tương quan giữa huyết áp ngoại biên và huyết áp trung tâm ở bệnh nhân tăng huyết áp đang được theo dõi tại phòng khám | Tim mạch học. achhoc.vn/khao-sat-tuong-quan-giua-huyet-ap-ngoai-bien-va-huyet-ap-trung-tam-o-benh-nhan-tang-huyet-ap-dang-duoc-theo-doi-tai-phong-kham/>, accessed: 04/10/2020.
11.
11. Dự án phòng chống Tăng huyết áp (2015), Chương trình mục tiêu quốc gia y tế, Bộ Y tế.
12.
12. Sharman James E., Marwick Thomas H., Gilroy Deborah, et al. (2013). Randomized Trial of Guiding Hypertension Management Using Central Aortic Blood Pressure Compared With Best-Practice Care. Hypertension, 62(6), 1138-1145.
13.
13. KosmalaW.,MarwickT.H.,StantonT.,etal.(2016). Guiding Hypertension Management Using Central Blood Pressure: Effect of Medication Withdrawal on Left Ventricular Function. AmJHypertens, 29(3), 319-325.
14.
14. Baba B.A., Johan P.T., and Mohan J.C. (2018). Comparsion of central aortic pressure to brachial artery pressure in hypertensive patients on drug treatment: An observational study. IndianHeartJ, 70, S208-S212.
15.
15. ChengH.-M.,ChuangS.-Y.,SungS.-H.,etal.2019 Consensus of the Taiwan Hypertension Society and Taiwan Society of Cardiology on the Clinical Application of Central Blood Pressure in the Management of Hypertension. ActaCardiolSin, 10.
16.
16. ChengH.-M.,ChuangS.-Y.,SungS.-H.,etal.(2013). Derivation and Validation of Diagnostic Thresholds for Central Blood Pressure Measurements Based on Long-Term Cardiovascular Risks. JAm Coll Cardiol, 62(19).
17.
17. Hội Tim mạch học Quốc gia Việt Nam (2018), Khuyến cáo về chẩn đoán và điều trị tăng huyết áp.
18.
18. OhishiM.,YoshidaT.,OhA.,etal.(2019). Analysis of antihypertensive treatment using real-world Japanese data-the retrospective study of antihypertensives for lowering blood pressure (REAL) study. HypertensRes, 42(7), 1057-1067.